About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Crebbptm1Dli
targeted mutation 1, David Livingston
MGI:1926888
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Crebbptm1Dli/Crebbptm1Dli involves: 129S6/SvEvTac * C57BL/6 MGI:2175793
ht2
Crebbptm1Dli/Crebbp+ involves: 129S6/SvEvTac * C57BL/6 MGI:2175794
cx3
Crebbptm1Dli/Crebbp+
Ep300tm1Dli/Ep300+
involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 MGI:3512279


Genotype
MGI:2175793
hm1
Allelic
Composition
Crebbptm1Dli/Crebbptm1Dli
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Crebbptm1Dli mutation (1 available); any Crebbp mutation (100 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging

nervous system

embryo




Genotype
MGI:2175794
ht2
Allelic
Composition
Crebbptm1Dli/Crebbp+
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Crebbptm1Dli mutation (1 available); any Crebbp mutation (100 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• severe splenomegaly in 73% of 12-18 month old mice but not in young mice (J:60630)
• spleen contains an excess of myeloid and erythroid cells (J:60630)
• mild but significant splenomegaly in 3-4 and 9-12 month old mutants (J:191503)

craniofacial
• craniofacial abnormalities

neoplasm
• hematologic neoplasia in animals 1 year or older, which include histiocytic sarcomas, a tumor of hematopoietic origin, and myelogenous and lymphocytic leukemias
• myelogenous and lymphocytic leukemias

hematopoietic system
• severe splenomegaly in 73% of 12-18 month old mice but not in young mice (J:60630)
• spleen contains an excess of myeloid and erythroid cells (J:60630)
• mild but significant splenomegaly in 3-4 and 9-12 month old mutants (J:191503)
• abundance of all hematopoietic cells types is significantly diminished in mice with splenomegaly (J:60630)
• increase in myeloid cells in mice with splenomegaly (J:60630)
• 2 of 14 mice at 3-4 months of age have small clusters of immature cells in the center of the marrow space, indicative of very early stages of myelodysplastic hematopoiesis (J:191503)
• mutants show an increase in Annexin V+ cells in the lineage-depleted (Lin-) fraction of the marrow enriched for stem and progenitor cells, indicating an increase in apoptosis in marrow progenitors
• in mice with splenomegaly (J:60630)
• mutants have fewer total colony-forming cells in the marrow than wild-type mice, most notably the granulocytic and monocytic colony-forming cells (J:191503)
• 9-12 month old mutants show a decrease in common myeloid progenitors (J:191503)
• in mice with splenomegaly
• bone marrow is more cellular than in wild type mice when corrected for body weight at 3-4 and 9-12 months of age
• more than 50% of 9-12 month old mutants exhibit either increased numbers of megakaryocytes or abnormal forms such as hyperlobulated cells or naked nuclei
• approximate 2-fold fewer long-term hematopoietic stem cells per femur at 9-12 months of age
• 22% of 9-12 month old mutants show leukocytes with a pseudo Pelger-Huet anomaly
• 55% of 9-12 month old mutants show hypersegemented granulocytes
• at 9-12 months of age
• lymphoid cell compartment is smaller at 9-12 months of age
• however, leukocyte, erythrocyte and platelet numbers are normal
• in mice with splenomegaly
• in mice with splenomegaly

immune system
• severe splenomegaly in 73% of 12-18 month old mice but not in young mice (J:60630)
• spleen contains an excess of myeloid and erythroid cells (J:60630)
• mild but significant splenomegaly in 3-4 and 9-12 month old mutants (J:191503)
• 22% of 9-12 month old mutants show leukocytes with a pseudo Pelger-Huet anomaly
• 55% of 9-12 month old mutants show hypersegemented granulocytes
• at 9-12 months of age
• lymphoid cell compartment is smaller at 9-12 months of age
• however, leukocyte, erythrocyte and platelet numbers are normal
• in mice with splenomegaly
• in mice with splenomegaly

cellular
• mutants treated with a 10-Gy split-dose total body irradiation die before wild-type mice do and none survive compared to 1/3 of wild-type mice that survive, indicating increased hypersensitivity to ionizing radiation
• a lower percentage of mutants treated with a split-dose of 11 Gy total body irradiation followed by a bone marrow graft survive compared to wild-type mice treated in the same way




Genotype
MGI:3512279
cx3
Allelic
Composition
Crebbptm1Dli/Crebbp+
Ep300tm1Dli/Ep300+
Genetic
Background
involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Crebbptm1Dli mutation (1 available); any Crebbp mutation (100 available)
Ep300tm1Dli mutation (1 available); any Ep300 mutation (98 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• unexpectedly, compound heterozygotes die in utero

embryo
• compound heterozygotes are smaller than control embryos
• compound heterozygotes exhibit a severe open neural tube defect similar to that observed in Ep300tm1Dli or Crebbptm1Dli homozygous mutants

growth/size/body
• compound heterozygotes are smaller than control embryos

nervous system
• compound heterozygotes exhibit a severe open neural tube defect similar to that observed in Ep300tm1Dli or Crebbptm1Dli homozygous mutants
• compound heterozygotes exhibit extensive exencephaly





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory